O'Shaughnessy Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

O'Shaughnessy Asset Management’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.5M	Buy	144,705 +13,637	+10%	+$187K	0.01%	815
2026 Q1	$1.63M	Sell	131,068 -25,273	-16%	-$339K	0.01%	965
2025 Q4	$1.97M	Buy	156,341 +7,931	+5%	+$90.7K	0.01%	850
2025 Q3	$1.49M	Buy	148,410 +643	+0.4%	+$5.77K	0.01%	952
2025 Q2	$1.2M	Sell	147,767 -18,923	-11%	-$143K	0.01%	988
2025 Q1	$1.4M	Sell	166,690 -8,909	-5%	-$74.4K	0.01%	849
2024 Q4	$1.39M	Sell	175,599 -28,190	-14%	-$236K	0.01%	803
2024 Q3	$1.76M	Sell	203,789 -1,151	-0.6%	-$9K	0.02%	684
2024 Q2	$1.3M	Buy	204,940 +15,655	+8%	+$99.4K	0.01%	744
2024 Q1	$1.15M	Buy	189,285 +39,706	+27%	+$224K	0.01%	777
2023 Q4	$908K	Buy	149,579 +46,802	+46%	+$208K	0.01%	787
2023 Q3	$434K	Buy	+102,777	New	+$383K	0.01%	982
2023 Q1	–	Sell	-11,712	Closed	-$23.3K	–	1480
2022 Q4	$23.3K	Sell	11,712 -542	-4%	-$1.22K	﹤0.01%	1296
2022 Q3	$25K	Buy	12,254 +542	+5%	+$1.52K	﹤0.01%	1258
2022 Q2	$37K	Buy	+11,712	New	+$42.4K	﹤0.01%	1166
2021 Q3	–	Sell	-61	Closed	–	–	2708
2021 Q2	$0	Buy	+61	New	+$347	﹤0.01%	2562

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

O'Shaughnessy Asset Management's AMRX Position: Q2 2026 in Review

O'Shaughnessy Asset Management increased its Amneal Pharmaceuticals (AMRX) stake by 10% in Q2 2026, buying an estimated $187K and bringing the position to 144,705 shares worth $2.5M. The position accounts for 0.01% of the portfolio, ranked #815.

O'Shaughnessy Asset Management first reported a position in AMRX in Q2 2021 and has held it in 16 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

O'Shaughnessy Asset Management held 144,705 shares of Amneal Pharmaceuticals worth $2.5M as of Q2 2026.
O'Shaughnessy Asset Management bought 13,637 Amneal Pharmaceuticals shares in Q2 2026, an estimated $187K.
Amneal Pharmaceuticals made up 0.01% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #815 holding.
O'Shaughnessy Asset Management first reported a position in Amneal Pharmaceuticals in Q2 2021 and has held it in 16 quarters since.
311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.